A Novel Hydrogen Sulfide Prodrug, SG1002, Promotes Hydrogen Sulfide and Nitric Oxide Bioavailability in Heart Failure Patients

Publisher: John Wiley & Sons Inc

E-ISSN: 1755-5922|33|4|216-226

ISSN: 1755-5914

Source: CARDIOVASCULAR THERAPEUTICS (ELECTRONIC), Vol.33, Iss.4, 2015-08, pp. : 216-226

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract